Steingold KA, Judd HL, Nieberg RK, et al. Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist. Am J Obstet Gynecol 1986;154:1241–1248.
219.
Garcia-Bunuel R, Berek JS, Woodruff JD. Luteomas of pregnancy. Obstet Gynecol 1975;45:407–414.
220.
Cronje HS. Luteoma of pregnancy. S Afr Med J 1984;66:59–60.
221.
Mazza V, Di Monte I, Ceccarelli PL, et al. Prenatal diagnosis of female pseudohermaphroditism associated with bilateral luteoma of pregnancy: case report. Hum Reprod 2002;17:821–824.
222.
Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. JUrol 2003;169:5–11.
223.
Latronico AC, Chrousos GP. Adrenocortical tumors. J Clin Endocrinol Metab 1997;82:1317–1324.
224.
Gaudio AD, Gaudio GAD. Virilizing adrenocortical tumors in adult women. Report of 10 patients, 2 of whom each had a tumor secreting only testosterone. Cancer 1993;72:1997–2003.
225.
Riddle O, Bates RW, Dykshorn S. The preparation, identification and assay of prolactin. A hormone of the anterior pituitary. Am J Physiol 1933;105:191–196.
226.
Frantz AG, Kleinberg DL. Prolactin: evidence that it is separate from growth hormone in human blood. Science 1970;170:745–747.
227.
Lewis UJ, Singh RN, Sinha YN, et al. Electrophoretic evidence for human prolactin. J Clin Endocrinol Metab 1971;33:153–156.
228.
Hwang P, Guyda H, Friesen H. Purification of human prolactin. J Biol Chem 1972;247:1955–1958.
229.
Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80:1523– 1631.
230.
Suh HK, Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 1974;39:928– 935.
231.
Guyda JH. Heterogeneity of human growth hormone and prolactin secreted in vitro: immunoassay and radioreceptor assay correlations. J Clin Endocrinol Metab 1975;41:953–967.
232.
Farkouh NH, Packer MG, Frantz AG. Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone. J Clin Endocrinol Metab 1979;48:1026–1032.
233.